Integrity Dividend Harvest Fund is sold by prospectus only. For more complete information an investor should consider the investment objectives, risks, and charges and expenses of the Fund carefully before investing. The prospectus contains this and other information about the Fund. You may obtain a prospectus at no cost from your financial advisor or at www.integrityvikingfunds.com. Please read the prospectus carefully before investing.
The performance data represents past performance, which does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. To obtain performance data current to the most recent month-end, an investor may call toll free 800-276-1262 or visit www.integrityvikingfunds.com.
IDHIX returns for the period ended 6/30/22 are: YTD -2.36%%, 1-year 9.45%, 3-year 9.40%, 5-year 8.86%, SI 8.75% - due to inception date of 8/1/2016, 10-year returns are unavailable; Total Annual Fund Operating Expenses After Fee Waivers and Expense Reimbursements are 0.70%; Total Annual Fund Operating Expenses Gross of Fee Waivers and Expense Reimbursements is 1.23%.
Because the Fund can only distribute what it earns, the distributions to shareholders could decline when dividend income from stocks in the portfolio decline. The Fund’s emphasis on dividend-paying stocks involves the risk that such stocks may fall out of favor with investors and underperform the market. Also, a company may reduce or eliminate its dividend, which could affect the Fund’s ability to generate income.
Preferred stocks are subject to the risks associated with other types of equity securities, such as potential volatility, as well as additional risks, such as risks related to deferral and omission of distributions; credit and subordination risk; interest rate risk; call, reinvestment and income risk; liquidity risk; risks related to limited voting rights; and risks related to special redemption rights.
The Fund may invest in securities of non-U.S. issuers, which have special risks. These risks include international economic and political developments, foreign government actions including restrictions on payments to non-domestic persons such as the Fund, less regulation, less information, currency fluctuations, and interruptions in currency flow. Investments in foreign securities also entail higher costs.
The Fund’s top 10 holdings represented 38.40% of the Fund as of 6/30/22: Abbvie 7.23%, Broadcom 5.74%, Verizon 4.36%, Pfizer 3.33%, Coca-Cola 3.19%, JPMorgan 3.14%, Kimberly-Clark 3.13%, NextEra Energy 2.83%, Merck & Co 2.82%, Philip Morris 2.63%; Referred companies represented 26.15% of the Fund: Abbvie 7.23%, Broadcom 5.74%, Verizon 4.36% Pfizer 3.33%, JPMorgan 3.14%, BlackRock 2.35%. The portfolio may or may not hold and is not restricted to the holdings listed.
All expressions of opinion are subject to change without notice in reaction to shifting market conditions. Data contained herein from third-party providers is obtained from what are considered reliable sources. However, its accuracy, completeness or reliability cannot be guaranteed.